Detailed Research: Economic Perspectives on DexCom, Pier 1 Imports, Gilead Sciences, Fitbit, Cloudera, and GoPro – What Drives Growth in Today's Competitive Landscape

NEW YORK, Oct. 23, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of DexCom, Inc. (NASDAQ:DXCM), Pier 1 Imports, Inc. (NYSE:PIR), Gilead Sciences, Inc. (NASDAQ:GILD), Fitbit, Inc. (NYSE:FIT), Cloudera, Inc. (NYSE:CLDR), and GoPro, Inc (NASDAQ:GPRO) including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

DXCM DOWNLOAD: http://Fundamental-Markets.com/register/?so=DXCM

PIR DOWNLOAD: http://Fundamental-Markets.com/register/?so=PIR

GILD DOWNLOAD: http://Fundamental-Markets.com/register/?so=GILD

FIT DOWNLOAD: http://Fundamental-Markets.com/register/?so=FIT

CLDR DOWNLOAD: http://Fundamental-Markets.com/register/?so=CLDR

GPRO DOWNLOAD: http://Fundamental-Markets.com/register/?so=GPRO

 (You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine  DexCom, Inc. (NASDAQ:DXCM), Pier 1 Imports, Inc. (NYSE:PIR), Gilead Sciences, Inc. (NASDAQ:GILD), Fitbit, Inc. (NYSE:FIT), Cloudera, Inc. (NYSE:CLDR), and GoPro, Inc (NASDAQ:GPRO) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed October 20, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).

-----------------------------------------

DEXCOM, INC (DXCM) REPORT OVERVIEW

DexCom's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, DexCom reported revenue of $170.6 vs $137.3 (up 24.3%) and diluted earnings per share $0.03 vs -$0.24. For the twelve months ended December 31, 2016 vs December 31, 2015, DexCom reported revenue of $573.3 vs $400.7 (up 43.1%) and diluted earnings per share -$0.78 vs -$0.72. DexCom is expected to report earnings on 11/01/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 12 analysts' forecasts, the consensus EPS forecast for the quarter is -$0.15. The reported EPS for the same quarter last year was -$0.22.

To read the full DexCom (DXCM) report, download it here: http://Fundamental-Markets.com/register/?so=DXCM

-----------------------------------------

PIER 1 IMPORTS (PIR) REPORT OVERVIEW

Pier 1 Imports' Recent Financial Performance

For the three months ended August 26, 2017 vs August 27, 2016, Pier 1 Imports reported net sales of $407.6 vs $405.8 (up 0.44%), diluted earnings per share -$0.10 vs -$0.05, and dividends per share $0.07 vs $0.07 (unchanged). For the twelve months ended February 25, 2017 vs February 27, 2016, Pier 1 Imports reported net sales of $1,828.4 vs $1,892.2 (down 3.4%), diluted earnings per share $0.37 vs $0.46 (down 19.6%), and dividends per share $0.28 vs $0.28 (unchanged).

To read the full Pier 1 Imports (PIR) report, download it here: http://Fundamental-Markets.com/register/?so=PIR

-----------------------------------------

GILEAD SCIENCES (GILD) REPORT OVERVIEW

Gilead Sciences' Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Gilead Sciences reported revenue of $7,141 vs $7,776 (down 8.2%), diluted earnings per share $2.33 vs $2.58 (down 9.7%), and dividends per share $0.52 vs $0.47 (up 10.6%). For the twelve months ended December 31, 2016 vs December 31, 2015, Gilead Sciences reported revenue of $30,390 vs $32,639 (down 6.9%), diluted earnings per share $9.94 vs $11.91 (down 16.5%), and dividends per share $1.84 vs $1.29 (up 42.6%). Gilead Sciences is expected to report earnings on 10/26/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 7 analysts' forecasts, the consensus EPS forecast for the quarter is $2.04. The reported EPS for the same quarter last year was $2.70.

To read the full Gilead Sciences (GILD) report, download it here: http://Fundamental-Markets.com/register/?so=GILD

-----------------------------------------

FITBIT (FIT) REPORT OVERVIEW

Fitbit's Recent Financial Performance

For the three months ended July 1, 2017 vs July 2, 2016, Fitbit reported revenue of $353.3 vs $586.5 (down 39.8%) and diluted earnings per share -$0.25 vs $0.03. For the twelve months ended December 31, 2016 vs December 31, 2015, Fitbit reported revenue of $2,169.5 vs $1,858.0 (up 16.8%) and diluted earnings per share -$0.47 vs $0.75. Fitbit is expected to report earnings on 11/01/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 7 analysts' forecasts, the consensus EPS forecast for the quarter is -$0.09. The reported EPS for the same quarter last year was $0.13.

To read the full Fitbit (FIT) report, download it here: http://Fundamental-Markets.com/register/?so=FIT

-----------------------------------------

CLOUDERA (CLDR) REPORT OVERVIEW

Cloudera’s Recent Financial Performance

For the three months ended July 31 2017 vs July 31, 2016, Cloudera reported revenue of $89.8 vs $64.5 (up 39.2%) and diluted earnings per share -$0.48 vs -$1.07. Cloudera is expected to report earnings on 12/07/2017.  According to Zacks Investment Research, based on 5 analysts' forecasts, the consensus EPS forecast for the quarter is -$0.24.

To read the full Cloudera (CLDR) report, download it here: http://Fundamental-Markets.com/register/?so=CLDR

-----------------------------------------

GOPRO INC (GPRO) REPORT OVERVIEW

GoPro's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, GoPro reported revenue of $296.5 vs $220.8 (up 34.3%) and diluted earnings per share -$0.22 vs -$0.66. For the twelve months ended December 31, 2016 vs December 31, 2015, GoPro reported revenue of $1,185.5 vs $1,620.0 (down 26.8%) and diluted earnings per share -$3.01 vs $0.25. GoPro is expected to report earnings on 11/01/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is -$0.05. The reported EPS for the same quarter last year was -$0.70.

To read the full GoPro (GPRO) report, download it here: http://Fundamental-Markets.com/register/?so=GPRO

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as  Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.